Clinical trial
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
NCT07017270 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
- Lead sponsor
- Unity Health Toronto
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 27, 2025
- Completion date
- September 30, 2027
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, dialysis, end stage kidney disease (esrd), kidney disease, chronic